Self-Organization, Decentralization, and Automation

Our tokenomics is designed to solve the “chicken-and-egg” problem of creating network effects. We have designed incentives so that the network creates itself, unfolding with only minimal nudging from Rejuve in the beginning, with the capacity to continue without much maintenance. Rejuve acts in a centralized manner when the network is beginning, for example, it houses a centralized HIPAA-compliant database. However, as HIPAA compliance becomes possible on IPFS-like decentralized systems, we will convert to decentralized. In the beginning, we will set aside some tokens to reward data contributors for their data, but that is just to start up the economy. Once there is an active market selling Product NFT shards, a portion of Rejuve’s shard sales will go towards the reward pool. At that point, the network becomes self-sustaining. People who buy token shards are an essential part of the network because they deliver tokens reliably to data contributors. Data contributors who are concerned about their longevity and their ability to afford longevity medications would be incentivized to join in the first place, but once they get in, their incentives snowball. Data contributors are incentivized to keep contributing data because each time they do so, they not only receive information about their longevity, but they also receive tokens, and find that the more they spend their tokens on submitting new data, the more tokens they have. If they keep contributing data, upping the quantity and quality of their data, they become more and more valuable to Rejuve, and get a larger and larger allocation of proceeds from longevity products. This makes the Product NFT shards more attractive to hold, increasing platform engagement. Incentives are also tuned towards getting the data that is most useful for longevity treatments. For example, the AI would likely allocate larger weights for the data of older persons because this data is more useful to understanding aging. These larger weights would allocate more product NFT shards, giving a larger up-front incentive to submit more data. Persons with particular diseases that shine a light on longevity would be paid even more.

All these incentives to submit data make a database full of useful data for longevity research, one that clinics and pharmaceutical companies would want to be in the network with. More network members mean more research directions, and more likelihood that the network will create blockbuster drugs, something which pharmacies would especially want to be distributors for. Finally, the automatic smart contract distributing every product NFT shard holder their share assures both data contributors and NFT shard buyers that the data is valuable and that they have true, lasting ownership.